These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 1736835)
21. Combination effect of recombinant human interleukin 1 alpha with antitumor drugs on syngeneic tumors in mice. Nakamura S; Kashimoto S; Kajikawa F; Nakata K Cancer Res; 1991 Jan; 51(1):215-21. PubMed ID: 1899039 [TBL] [Abstract][Full Text] [Related]
22. [Antitumor activity of a new platinum complex, (R)-(-)-2-aminomethylpyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II), against cisdiamminedichloroplatinum (II)-resistant murine leukemia cell line]. Akamatsu K; Endo K; Matsumoto T; Kamisango K; Morikawa K; Koizumi M; Mitsui H; Koizumi K; Matsuno T Gan To Kagaku Ryoho; 1990 Jan; 17(1):73-8. PubMed ID: 2404458 [TBL] [Abstract][Full Text] [Related]
23. [Combination chemotherapy of HO-221, a derivative of benzoylphenylurea with various anticancer agents against human cancer xenografts in nude mice]. Fujita F; Fujita M; Inaba H; Sugimoto T; Okuyama Y; Taguchi T Gan To Kagaku Ryoho; 1991 Oct; 18(13):2263-70. PubMed ID: 1929447 [TBL] [Abstract][Full Text] [Related]
24. [Combined effect of HO-221 with various antitumor agents against L 1210 leukemia]. Nakajima T; Masuda H; Okamoto T; Watanabe M; Yokoyama K; Yamada N; Tsukagoshi S; Taguchi T Gan To Kagaku Ryoho; 1991 Apr; 18(4):555-62. PubMed ID: 2012397 [TBL] [Abstract][Full Text] [Related]
25. [Synergism of sobuzoxane in combination with doxorubicin against leukemia P388 in mice]. Dai ZQ; Xu JY; Yuan XJ; Cai JC Zhongguo Yao Li Xue Bao; 1996 Jan; 17(1):69-71. PubMed ID: 8737460 [TBL] [Abstract][Full Text] [Related]
26. Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing mice. Novotny L; Rauko P; Liska J; Elford HL; Szekeres T Cancer Lett; 2006 Feb; 233(1):178-84. PubMed ID: 15885888 [TBL] [Abstract][Full Text] [Related]
27. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines. Tsuruo T; Yusa K; Sudo Y; Takamori R; Sugimoto Y Cancer Res; 1989 Oct; 49(20):5537-42. PubMed ID: 2790778 [TBL] [Abstract][Full Text] [Related]
28. [Effectiveness of combined action of vitamins A, E and C and cyclophosphane or adriamycin on growth of transplanted tumors in mice]. Mosienko VS; Khasanova LT; Sukolinskiĭ VN; Morozkina TS Eksp Onkol; 1990; 12(3):55-7. PubMed ID: 2344827 [TBL] [Abstract][Full Text] [Related]
29. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152). Fujimoto K; Oka T; Morimoto M Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218 [TBL] [Abstract][Full Text] [Related]
30. Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia. Tsuruo T; Oh-Hara T; Sudo Y; Naito M Anticancer Res; 1993; 13(2):357-61. PubMed ID: 8517647 [TBL] [Abstract][Full Text] [Related]
31. Therapeutic synergy of trimetrexate (CI-898) in combination with doxorubicin, vincristine, cytoxan, 6-thioguanine, cisplatin, or 5-fluorouracil against intraperitoneally implanted P388 leukemia. Leopold WR; Dykes DJ; Griswold DP NCI Monogr; 1987; (5):99-104. PubMed ID: 2963231 [TBL] [Abstract][Full Text] [Related]
32. L-histidinol: preclinical therapeutic studies in combination with antitumor agents and pharmacokinetic studies in mice. Zaharko D; Plowman J; Waud W; Dykes D; Malspeis L Cancer Res; 1992 Jul; 52(13):3604-9. PubMed ID: 1617631 [TBL] [Abstract][Full Text] [Related]
33. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials. Thigpen T; Vance R; Puneky L; Khansur T Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816 [TBL] [Abstract][Full Text] [Related]
34. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes. Siddik ZH; al-Baker S; Thai G; Khokhar AR Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929 [TBL] [Abstract][Full Text] [Related]
35. Antitumor activity of menogaril alone, and in combination against human mammary cancer models in mice and rats. Yoshida M; Fujioka A; Nakano K; Kobunai T; Saito H; Toko T; Takeda S; Unemi N Anticancer Res; 1996; 16(3A):1155-9. PubMed ID: 8702227 [TBL] [Abstract][Full Text] [Related]
36. [Combined effect of PT-050 (recombinant human TNF) and antitumor drugs on syngeneic murine tumors]. Nakata K; Yoshida H; Kashimoto S; Sohmura Y; Nakamura S; Taguchi T Gan To Kagaku Ryoho; 1986 Oct; 13(11):3186-93. PubMed ID: 3096217 [TBL] [Abstract][Full Text] [Related]
37. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma. Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474 [TBL] [Abstract][Full Text] [Related]
38. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
39. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388. Góra-Tybor J; Robak T Acta Haematol Pol; 1993; 24(2):177-82. PubMed ID: 8103959 [TBL] [Abstract][Full Text] [Related]
40. Combinations of mesna with cyclophosphamide or adriamycin in the treatment of mice with tumors. Bernacki RJ; Bansal SK; Gurtoo HL Cancer Res; 1987 Feb; 47(3):799-802. PubMed ID: 3100025 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]